{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:11:49Z","timestamp":1772140309026,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imbio.2017.10.036","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T16:34:25Z","timestamp":1508171665000},"page":"259-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: Is TNF alpha the link?"],"prefix":"10.1016","volume":"223","author":[{"given":"Tali","family":"Drori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gili","family":"Givaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merav","family":"Lidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pnina","family":"Langevitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.imbio.2017.10.036_bib0005","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00296-011-1969-9","article-title":"Cytokine modulators in the treatment of sarcoidosis","volume":"31","author":"Bargagli","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.imbio.2017.10.036_bib0010","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-010-8242-y","article-title":"Immunology, autoimmunity, and autoantibodies in Parkinson\u2019s disease","volume":"42","author":"Benkler","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2017.10.036_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0090-3019(81)90144-0","article-title":"Neurosarcoidosis: a review of the rarer manifestations","volume":"15","author":"Cahill","year":"1981","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.imbio.2017.10.036_bib0020","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal anti- inflammatory drug use and the risk for Parkinson\u2019s disease","volume":"58","author":"Chen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.imbio.2017.10.036_bib0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.imbio.2017.10.036_bib0030","article-title":"Immunohistochemical characterization and TNF-\u03b1 expression of the granulomatous infiltration of the brainstem in a case of sudden death due to neurosarcoidosis","volume":"20","author":"D'Errico","year":"2011","journal-title":"Forensic Sci. Int."},{"issue":"2","key":"10.1016\/j.imbio.2017.10.036_bib0035","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A","article-title":"Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1","volume":"29","author":"Eugster","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2017.10.036_bib0040","series-title":"Recent Developments in Parkinson\u2019s Disease","first-page":"153","article-title":"Unified parkinson\u2019s disease rating scale","author":"Fahn","year":"1987"},{"key":"10.1016\/j.imbio.2017.10.036_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.imbio.2017.10.036_bib0050","first-page":"e125","article-title":"Neurosarcoidosis, report of 30 cases and a literature survey","volume":"22","author":"Gascon-Bayarri","year":"2011","journal-title":"Eur. J. Intern. Med."},{"issue":"2","key":"10.1016\/j.imbio.2017.10.036_bib0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.imbio.2017.10.036_bib0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","article-title":"Environmental toxins and Parkinson's disease","volume":"54","author":"Goldman","year":"2014","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.imbio.2017.10.036_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2014.01.035","article-title":"Diagnostic criteria for sarcoidosis","volume":"13","author":"Heinle","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imbio.2017.10.036_bib0070","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.imbio.2017.10.036_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.imbio.2017.10.036_bib0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00702-012-0842-7","article-title":"Autoimmunity, dendritic cells and relevance for Parkinson's disease","volume":"120","author":"Koutsilieri","year":"2013","journal-title":"J. Neural Transm."},{"issue":"1\u20134","key":"10.1016\/j.imbio.2017.10.036_bib0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000333222","article-title":"Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden","volume":"10","author":"Li","year":"2012","journal-title":"Neurodegener. Dis."},{"issue":"2","key":"10.1016\/j.imbio.2017.10.036_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000320027","article-title":"MPTP-induced neuroinflammation increases the expression of pro-inflammatory cytokines and their receptors in mouse brain","volume":"18","author":"Lofrumento","year":"2011","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.imbio.2017.10.036_bib0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","article-title":"Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease","volume":"98","author":"Luchtman","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.imbio.2017.10.036_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.imbio.2017.10.036_bib0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neulet.2006.12.003","article-title":"p53 protein, interferon-gamma and NF- kappa B levels are elevated in the parkinsonian brain","volume":"414","author":"Mogi","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.imbio.2017.10.036_bib0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.07.2008.0569","article-title":"Sarcoidosis with basal ganglia infiltration presenting as Parkinsonism","author":"Papapetropulos","year":"2009","journal-title":"BMJ Case Rep."},{"issue":"3","key":"10.1016\/j.imbio.2017.10.036_bib0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bbadis.2014.11.019","article-title":"TNF-(regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells","volume":"1852","author":"Prajapati","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.imbio.2017.10.036_bib0120","first-page":"275","article-title":"Anti-TNF-\u00e9 therapy in the management of severe neurosarcoidosis: a report of five cases from a single center and literature review","volume":"32","author":"Riancho-Zarrabeitia","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"8","key":"10.1016\/j.imbio.2017.10.036_bib0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ajcp\/19.8.725","article-title":"Sarcoidosis; a clinicopathologic review of 300 cases, including 22 autopsies","volume":"19","author":"Ricker","year":"1949","journal-title":"Am. J. Clin. Pathol."},{"issue":"18","key":"10.1016\/j.imbio.2017.10.036_bib0130","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","article-title":"Autoimmune disease and risk for Parkinson disease. A population-based case-control study","volume":"73","author":"Rugbjerg","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.imbio.2017.10.036_bib0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/mds.870040309","article-title":"Cerebral sarcoidosis presenting as supraneuclear palsy with hypokinetic rigid syndrome","volume":"4","author":"Schlegel","year":"1989","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.imbio.2017.10.036_bib0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study","volume":"11","author":"The Lenercept Multiple Sclerosis Study Group and the University of British Columbia MS\/MRI Analysis Group","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.imbio.2017.10.036_bib0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.18579\/jpcrkc\/2013\/12\/2\/79133","article-title":"Parkinson's disease: a review","volume":"12","author":"Urooj","year":"2013","journal-title":"J. Pharm. Res."},{"issue":"2","key":"10.1016\/j.imbio.2017.10.036_bib0150","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/1531-8257(199903)14:2<262::AID-MDS1011>3.0.CO;2-6","article-title":"Parkinsonism associated with Sjorgren's syndrome: three cases and a review of the literature","volume":"14","author":"Walker","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.imbio.2017.10.036_bib0155","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","article-title":"Nonsteroidal anti- inflammatory drugs may protect against Parkinson disease","volume":"69","author":"Wahner","year":"2007","journal-title":"Neurology"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298517301778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298517301778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:43:45Z","timestamp":1759250625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298517301778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0171298517301778"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2017.10.036","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrapyramidal signs in neurosarcoidosis versus multiple sclerosis: Is TNF alpha the link?","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2017.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}